{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:20Z","timestamp":1793390840489,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011925","name":"European Society of\u00a0Human Reproduction and Embryology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1171592"],"award-info":[{"award-number":["APP1171592"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1078444"],"award-info":[{"award-number":["APP1078444"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005617","name":"BHF Centre of Research Excellence, Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003744","name":"Stiftelsen Handlanden Hjalmar Svenssons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005709","name":"Endocrine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010382","name":"European Society of Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.eclinm.2023.102162","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T01:34:18Z","timestamp":1691544858000},"page":"102162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"63","author":[{"given":"Simon","family":"Alesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-3849","authenticated-orcid":false,"given":"Maria","family":"Forslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Romualdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-4876","authenticated-orcid":false,"given":"Alexia","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau Thien","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma Feldman","family":"Witchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Teede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eclinm.2023.102162_bib1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102162_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib4","first-page":"17","article-title":"Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH","volume":"18","author":"Bani Mohammad","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.eclinm.2023.102162_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102162_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/obe.2007.0019","article-title":"Obesity and polycystic ovary syndrome","volume":"3","author":"Sam","year":"2007","journal-title":"Obes Manag"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib8","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102162_bib9","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.14913","article-title":"Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review","volume":"99","author":"Forslund","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102162_bib12","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"Harborne","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"36","key":"10.1016\/j.eclinm.2023.102162_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004526","article-title":"Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis","volume":"95","author":"Zeng","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.eclinm.2023.102162_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2016.05.003","article-title":"Androgen excess: investigations and management","volume":"37","author":"Lizneva","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.eclinm.2023.102162_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy","year":"2011","journal-title":"Int J Womens Health"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102162_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1470-2045(09)70229-3","article-title":"Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target","volume":"10","author":"Chen","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2017-02052","article-title":"Treatment options for hirsutism: a systematic review and network meta-analysis","volume":"103","author":"Barrionuevo","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2007.03105.x","article-title":"A\u00a0systematic review of commonly used medical treatments for hirsutism in women","volume":"68","author":"Koulouri","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2023.102162_bib20","series-title":"National Health Medical Research Council. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines Canberra","author":"National Health and Medical Research Council","year":"2009"},{"key":"10.1016\/j.eclinm.2023.102162_bib21","series-title":"Manual for ESHRE guideline development","author":"Vermeulen","year":"2017"},{"key":"10.1016\/j.eclinm.2023.102162_bib22","series-title":"Technical report for the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Monash University","author":"Mousa","year":"2023"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102162_bib23","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/jcr\/ucw085","article-title":"Single-paper meta-analysis: benefits for study summary, theory testing, and replicability","volume":"43","author":"McShane","year":"2017","journal-title":"J\u00a0Consum Res"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102162_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/humrep\/dez272","article-title":"Harmonising research outcomes for polycystic ovary syndrome: an international multi-stakeholder core outcome set","volume":"35","author":"Al Wattar","year":"2020","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpag.2013.09.010","article-title":"Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study","volume":"27","author":"Tartagni","year":"2014","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.fertnstert.2022.09.324","article-title":"Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome","volume":"119","author":"Dumesic","year":"2023","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib28","first-page":"205","article-title":"Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese\/overweight PCOS women under hypocaloric diet","volume":"15","author":"Amiri","year":"2014","journal-title":"J\u00a0Reprod Infertil"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102162_bib29","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/eje.0.1410361","article-title":"Comparison of finasteride versus flutamide in the treatment of hirsutism","volume":"141","author":"Falsetti","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.fertnstert.2004.02.118","article-title":"Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women","volume":"82","author":"Tartagni","year":"2004","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4183\/aeb.2017.84","article-title":"Comparison of finasteride, metformin, and finasteride plus metformin IN PCOS","volume":"13","author":"Diri","year":"2017","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102162_bib33","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2013-1040","article-title":"Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study","volume":"98","author":"Ganie","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102162_bib34","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102162_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.numecd.2013.04.016","article-title":"In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone","volume":"24","author":"Mazza","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102162_bib37","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1160\/TH17-04-0248","article-title":"Differential effects on haemostatic markers by metformin and the contraceptive pill: a randomized comparative trial in PCOS","volume":"117","author":"Burchall","year":"2017","journal-title":"Thromb Haemost"},{"issue":"9-10","key":"10.1016\/j.eclinm.2023.102162_bib38","first-page":"455","article-title":"Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome","volume":"59","author":"Hagag","year":"2014","journal-title":"J\u00a0Reprod Med"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/jc.2017-01186","article-title":"Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism: a double-blind randomized controlled trial","volume":"103","author":"Moretti","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.contraception.2011.12.011","article-title":"The effects of 2 mg chlormadinone acetate\/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome","volume":"86","author":"Vieira","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eclinm.2023.102162_bib43","first-page":"7","article-title":"Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome","volume":"21","author":"Mehrabian","year":"2016","journal-title":"J\u00a0Res Med Sci"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-17-0516","article-title":"Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial","volume":"177","author":"Alpa\u00f1\u00e9s","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib45","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib46","doi-asserted-by":"crossref","first-page":"bvaa032","DOI":"10.1210\/jendso\/bvaa032","article-title":"Toward a treatment normalizing ovulation rate in adolescent girls with polycystic ovary syndrome","volume":"4","author":"Ib\u00e1\u00f1ez","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib47","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/s41598-021-86317-9","article-title":"The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat","volume":"11","author":"de Zegher","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2023.102162_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4192940","article-title":"Low-dose spironolactone-pioglitazone-metformin normalizes circulating fetuin-A concentrations in adolescent girls with polycystic ovary syndrome","volume":"2018","author":"D\u00edaz","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102162_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12500","article-title":"Towards a circulating marker of hepato-visceral fat excess: S100A4 in adolescent girls with polycystic ovary syndrome - evidence from randomized clinical trials","volume":"14","author":"Malpique","year":"2019","journal-title":"Pediatr Obes"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102162_bib50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jadohealth.2017.04.010","article-title":"Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome","volume":"61","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.eclinm.2023.102162_bib51","series-title":"Australian medicines handbook 2023","author":"Australian Medicines Handbook Pty Ltd","year":"2023"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib52","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.1967.tb14686.x","article-title":"Induced genital anomalies","volume":"142","author":"Goldman","year":"1967","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.eclinm.2023.102162_bib53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/IJWH.S59852","article-title":"Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community","volume":"6","author":"Asare","year":"2014","journal-title":"Int J Womens Health"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102162_bib54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2275(20)30144-9","article-title":"Estrogen receptor-mediated repression of human hepatic lipase gene transcription","volume":"43","author":"Jones","year":"2002","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.eclinm.2023.102162_bib55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.12659\/AJCR.890679","article-title":"Bicalutamide-induced hepatotoxicity: a rare adverse effect","volume":"15","author":"Hussain","year":"2014","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1665-2681(19)31595-9","article-title":"Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature","volume":"10","author":"Javier","year":"2011","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.18773\/austprescr.2015.002","article-title":"Choosing a combined oral contraceptive pill","volume":"38","author":"Stewart","year":"2015","journal-title":"Aust Prescr"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0019-5154.60342","article-title":"Hirsutism: evaluation and treatment","volume":"55","author":"Sachdeva","year":"2010","journal-title":"Indian J Dermatol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102162_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/endo-97-1-52","article-title":"Antiandrogenic effect of spirolactones: mechanism of action","volume":"97","author":"Corvol","year":"1975","journal-title":"Endocrinology"}],"updated-by":[{"DOI":"10.1016\/j.eclinm.2024.103009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023003395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023003395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:48Z","timestamp":1762899768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023003395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"alternative-id":["S2589537023003395"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102162","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102162"}}